A male patient underwent an aquablation therapy for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procept) became aware that after aquablation therapy was completed and when the resectoscope was inserted into the patient to begin hemostasis, the patient went into cardiac arrest.Cardiopulmonary resuscitation was performed, and emergency medical services were notified to transfer the patient.It was reported that the patient was stabilized and had been discharged from the hospital.No malfunction of the aquabeam robotic system was reported.
|
Additional information was received on 29-apr-2024 indicating that the patient had unspecified cardiac pre-existing conditions, but had received cardiac clearance the day of aquablation therapy.The treating surgeon is unsure exactly what caused the cardiac arrest; however, confirmed that it was not related to aquablation.H11: additional manufacturer narrative: the aquabeam robotic system is a reusable device; therefore it is currently in the possession of the user facility.The investigation of this event consisted of a review of the device history record (dhr) and instructions for use (ifu).A review of the device history record (dhr) ab2000-b/serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system's instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 3.Contraindications do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.The aquabeam robotic system is a reusable device; therefore, it is currently in possession of the user facility.It was reported that after aquablation therapy, the patient went into cardiac arrest and was resuscitated.The patient was reported to have unspecified cardiac pre-existing conditions, but received cardiac clearance the day of aquablation therapy.The treating surgeon is unsure what caused the patient's cardiac arrest; however, he confirmed that it was not related to the aquabeam robotic system.Based on the event details, plus a review of the dhr and ifu, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|